Algernon Pharmaceuticals (AGNPF) Projected to Announce Earnings on Friday

Algernon Pharmaceuticals (OTCMKTS:AGNPF) is expected to post its resultson Friday, July 24th. Analysts expect Algernon Pharmaceuticals to announce earnings of ($4.9720) per share for the quarter.

Algernon Pharmaceuticals Price Performance

Algernon Pharmaceuticals stock opened at $0.29 on Thursday. Algernon Pharmaceuticals has a 12-month low of $0.23 and a 12-month high of $0.64. The firm’s fifty day moving average price is $0.31 and its 200 day moving average price is $0.16.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.

The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).